P N Tariot
Overview
Explore the profile of P N Tariot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talkad H, Chen Y, Bress A, Langbaum J, Tariot P, Pruzin J
JAR Life
. 2024 Dec;
13:126-134.
PMID: 39698060
Background: Dementia disproportionately affects Hispanic communities, which may be partially attributable to disparities in resources to address modifiable risk factors. Addressing risk factors at younger ages would likely confer greater...
2.
Walsh T, Duff L, Riviere M, Tariot P, Doak K, Smith M, et al.
J Prev Alzheimers Dis
. 2023 Jun;
10(3):453-463.
PMID: 37357285
Background: Alzheimer's disease (AD) prevention trials require a large outreach and screening funnel to identify cognitively unimpaired adults who meet the study's inclusion criteria, such as certain clinical or demographic...
3.
Langbaum J, High N, Nichols J, Kettenhoven C, Reiman E, Tariot P
J Prev Alzheimers Dis
. 2020 Sep;
7(4):242-250.
PMID: 32920626
Background: Recruitment for Alzheimer's disease (AD)-focused studies, particularly prevention studies, is challenging due to the public's lack of awareness about study opportunities coupled with studies' inclusion and exclusion criteria, resulting...
4.
Fuller J, Cronin-Golomb A, Gatchel J, Norton D, Guzman-Velez E, Jacobs H, et al.
J Prev Alzheimers Dis
. 2019 Feb;
6(2):112-120.
PMID: 30756118
The study of individuals with autosomal dominant Alzheimer's disease affords one of the best opportunities to characterize the biological and cognitive changes of Alzheimer's disease that occur over the course...
5.
Graf A, Risson V, Gustavsson A, Bezlyak V, Caputo A, Tariot P, et al.
J Prev Alzheimers Dis
. 2019 Feb;
6(2):85-89.
PMID: 30756114
We are launching the Insights to Model Alzheimer's Progression in Real Life study in parallel with the Alzheimer Prevention Initiative Generation Program. This is a 5-year, multinational, prospective, longitudinal, non-interventional...
6.
Rios-Romenets S, Giraldo-Chica M, Lopez H, Piedrahita F, Ramos C, Acosta-Baena N, et al.
J Prev Alzheimers Dis
. 2018 Feb;
5(1):49-54.
PMID: 29405233
The Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease (ADAD) trial evaluates the anti-amyloid-β antibody crenezumab in cognitively unimpaired persons who, based on genetic background and age, are at high...
7.
Hendrix S, Ellison N, Stanworth S, Otcheretko V, Tariot P
J Prev Alzheimers Dis
. 2017 Dec;
2(3):165-171.
PMID: 29226942
Background: Several randomized trials have demonstrated superiority of memantine-cholinesterase inhibitor combination therapy in patients with moderate to severe Alzheimer's disease, yet a recent publication reported no additional benefit of add-on...
8.
Lopez Lopez C, Caputo A, Liu F, Riviere M, Rouzade-Dominguez M, Thomas R, et al.
J Prev Alzheimers Dis
. 2017 Nov;
4(4):242-246.
PMID: 29181489
Alzheimer's disease pathology begins decades before the onset of clinical symptoms. This provides an opportunity for interventional clinical trials to potentially delay or prevent the onset of cognitive impairment or...
9.
Saunders K, Langbaum J, Holt C, Chen W, High N, Langlois C, et al.
J Prev Alzheimers Dis
. 2015 Oct;
1(2):74-79.
PMID: 26491650
Background: The Arizona Alzheimer's Consortium (AAC) created the Arizona Alzheimer's Registry, a screening and referral process for people interested in participating in Alzheimer's disease related research. The goals of the...
10.
Langbaum J, Hendrix S, Ayutyanont N, Bennett D, Shah R, Barnes L, et al.
J Prev Alzheimers Dis
. 2015 Aug;
2(1):2-3.
PMID: 26273569
No abstract available.